[ECG and BP monitoring in patients with stable angina and essential hypertension on therapy with monocinque].
The authors studied ECG and arterial pressure (AP) parameters in 24 patients with stable angina and arterial hypertension aged 57.9 +/- 1.6 years, receiving 14-day complex therapy including administration of monocinque in a dose of 20 mgs 2 times a day. A portable Digitrak-Plus Zymed Holter 1810 device (USA) was used to monitor ECG, and a portable Meditech ABPM-04 device (Hungary)--to monitor AP. The therapy substantially reduced episode frequency as well as total length and amplitude of ST segment depression. At the same time, the patients displayed decrease of day and night systolic and diastolic AP, as well as of their mean daily values.
Zaslavskaia
R M
RM
Shcherban'
E A
EA
Logvinenko
S I
SI
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D015924:Blood Pressure Monitors; D003692:Delayed-Action Preparations; D015716:Electrocardiography, Ambulatory; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007548:Isosorbide Dinitrate / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D020030:Nitric Oxide Donors / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D020030:Nitric Oxide Donors; D014665:Vasodilator Agents; D007548:Isosorbide Dinitrate; C030397:isosorbide-5-mononitrate